Double-Blind Naltrexone in Kleptomania

Exclusion Criteria

• •1. unstable medical illness or clinically significant abnormalities on prestudy laboratory tests or physical examination
• •2. history of seizures
• •3. myocardial infarction within 6 months
• •4. current pregnancy or lactation, or inadequate contraception in women of childbearing potential
• •5. clinically significant suicidality
• •6. current or recent (past 3 months) DSM-IV substance abuse or dependence
• •7. illegal substance within 2 weeks of study initiation
• •8. initiation of psychotherapy or behavior therapy from a mental health professional for the treatment of kleptomania within 3 months prior to study baseline
• •9. initiation of a psychotropic medication within 2 months prior to study inclusion
• •10. previous treatment with naltrexone
• •11. treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline.